| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AUPQ2325AAUPQ232599A0 (en) | 1999-08-19 | 1999-08-19 | Drug for treating fractures |
| CA002381302ACA2381302A1 (en) | 1999-08-19 | 2000-08-17 | Drug for treating fractures |
| KR1020027002160AKR20020027562A (en) | 1999-08-19 | 2000-08-17 | Drug for treating tractures |
| JP2001518059AJP2003507426A (en) | 1999-08-19 | 2000-08-17 | Fracture treatment |
| HK03100502.8AHK1048441B (en) | 1999-08-19 | 2000-08-17 | Drug for treating fractures |
| PCT/AU2000/000982WO2001013922A1 (en) | 1999-08-19 | 2000-08-17 | Drug for treating fractures |
| NZ517538ANZ517538A (en) | 1999-08-19 | 2000-08-17 | Drug for treating fractures |
| EP00952791AEP1214079A4 (en) | 1999-08-19 | 2000-08-17 | Drug for treating fractures |
| CNB008117659ACN100345548C (en) | 1999-08-19 | 2000-08-17 | Drugs used to treat broken bones |
| AU65488/00AAU781068B2 (en) | 1999-08-19 | 2000-08-17 | Drug for treating fractures |
| IL14816600AIL148166A0 (en) | 1999-08-19 | 2000-08-17 | Drug for treating fractures |
| HU0202396AHUP0202396A3 (en) | 1999-08-19 | 2000-08-17 | Medicaments useful for treating fractures |
| BR0013416-3ABR0013416A (en) | 1999-08-19 | 2000-08-17 | Drug, use of a drug selected from the group consisting of at least one bisphosphonate, and method for treating a fractured bone |
| PL00353485APL353485A1 (en) | 1999-08-19 | 2000-08-17 | Drug for treating fractures |
| SK238-2002ASK2382002A3 (en) | 1999-08-19 | 2000-08-17 | Drug for treating fractures |
| NO20020784ANO20020784D0 (en) | 1999-08-19 | 2002-02-18 | Medication for the treatment of fractures |
| ZA200202160AZA200202160B (en) | 1999-08-19 | 2002-03-15 | Drug for treating fractures. |
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AUPQ2325AAUPQ232599A0 (en) | 1999-08-19 | 1999-08-19 | Drug for treating fractures |
| Publication Number | Publication Date |
|---|---|
| AUPQ232599A0true AUPQ232599A0 (en) | 1999-09-09 |
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AUPQ2325AAbandonedAUPQ232599A0 (en) | 1999-08-19 | 1999-08-19 | Drug for treating fractures |
| Country | Link |
|---|---|
| EP (1) | EP1214079A4 (en) |
| JP (1) | JP2003507426A (en) |
| KR (1) | KR20020027562A (en) |
| CN (1) | CN100345548C (en) |
| AU (1) | AUPQ232599A0 (en) |
| BR (1) | BR0013416A (en) |
| CA (1) | CA2381302A1 (en) |
| HK (1) | HK1048441B (en) |
| HU (1) | HUP0202396A3 (en) |
| IL (1) | IL148166A0 (en) |
| NO (1) | NO20020784D0 (en) |
| NZ (1) | NZ517538A (en) |
| PL (1) | PL353485A1 (en) |
| SK (1) | SK2382002A3 (en) |
| WO (1) | WO2001013922A1 (en) |
| ZA (1) | ZA200202160B (en) |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUP0303013A3 (en)* | 2001-02-06 | 2007-06-28 | Royal Alexandra Hosp Children | A drug for treatment of osteonecrosis and for the management of patients at risk developing osteonecrosis |
| US20040157798A1 (en)* | 2001-04-03 | 2004-08-12 | Little David Graham | Drug for use in bone grafting |
| AUPR553701A0 (en)* | 2001-06-07 | 2001-07-12 | Royal Alexandra Hospital For Children, The | A device for the delivery of a drug to a fractured bone |
| EP1508343B1 (en)* | 2003-08-21 | 2015-11-04 | AddBIO AB | Bisphosponate coated implant device and method therefor |
| WO2005027921A1 (en)* | 2003-09-19 | 2005-03-31 | Pfizer Products Inc. | Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and a bisphosphonate |
| ITMI20040218A1 (en)* | 2004-02-10 | 2004-05-10 | Abiogen Pharma Spa | USE OF SODIUM NERHYDRONATE TO PROMOTE BONE NEOFORMATION |
| ITMI20040641A1 (en)* | 2004-03-31 | 2004-06-30 | Tb Technology S R L | BIFUNCTIONAL BIOADHESIVE COMPOSITIONS FOR ORAL IMPLANTOLOGY |
| AR048742A1 (en)* | 2004-12-22 | 2006-05-24 | Gador Sa | INTRA-ORAL MEDICINES APPLICATION SYSTEM |
| JP5426168B2 (en) | 2005-10-27 | 2014-02-26 | トーメン メディカル アーゲー | Dental implant and manufacturing method thereof |
| US8882740B2 (en) | 2009-12-23 | 2014-11-11 | Stryker Trauma Gmbh | Method of delivering a biphosphonate and/or strontium ranelate below the surface of a bone |
| CN114532937B (en)* | 2020-11-18 | 2024-11-01 | 中国人民解放军海军军医大学第一附属医院 | Auxiliary device for small intestinal endoscope |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR8107560A (en)* | 1981-11-19 | 1983-07-05 | Luiz Romariz Duarte | ULTRASONIC STIMULATION OF BONE FRACTURE CONSOLIDATION |
| WO1993011786A1 (en)* | 1991-12-17 | 1993-06-24 | Procter & Gamble Pharmaceuticals, Inc. | Methods for the treatment of osteoporosis using bisphosphonates and parathyroid hormone |
| EP0600834A1 (en)* | 1992-11-30 | 1994-06-08 | Ciba-Geigy Ag | Use of methanebisphosphonic acid derivatives for the manufacture of a medicament for fracture healing |
| AU670337B2 (en)* | 1992-11-30 | 1996-07-11 | Novartis Ag | Use of certain methanebisphosphonic acid derivatives in fracture healing |
| CA2151240A1 (en)* | 1992-12-23 | 1994-07-07 | Donna T. Whiteford | Biophosphonate/estrogen therapy for treating and preventing bone loss |
| US5403829A (en)* | 1993-03-24 | 1995-04-04 | Leiras Oy | Use of bisphosphonates in endo-osteal bone surgery |
| US5646134A (en)* | 1994-04-21 | 1997-07-08 | Merck & Co., Inc. | Alendronate therapy to prevent loosening of, or pain associated with, orthopedic implant devices |
| GB9408775D0 (en)* | 1994-05-04 | 1994-06-22 | Ciba Geigy Ag | Use of certain methanebisphosphonic acid derivatives to prevent prothesis loosening and prothesis migration |
| AU703887B2 (en)* | 1995-06-06 | 1999-04-01 | Merck & Co., Inc. | Bisphosphonate therapy for bone loss associated with rheumatoid arthritis |
| US5616571A (en)* | 1995-06-06 | 1997-04-01 | Merck & Co., Inc. | Bisphosphonates prevent bone loss associated with immunosuppressive therapy |
| US5853759A (en)* | 1996-05-17 | 1998-12-29 | Merck & Co.. Inc. | Effervescent alendronate formulation |
| GB9613722D0 (en)* | 1996-06-28 | 1996-08-28 | Univ Liverpool | Chemical compounds |
| Publication number | Publication date |
|---|---|
| HK1048441A1 (en) | 2003-04-04 |
| NO20020784L (en) | 2002-02-18 |
| JP2003507426A (en) | 2003-02-25 |
| PL353485A1 (en) | 2003-11-17 |
| NO20020784D0 (en) | 2002-02-18 |
| EP1214079A4 (en) | 2004-03-24 |
| CN100345548C (en) | 2007-10-31 |
| HK1048441B (en) | 2008-02-22 |
| ZA200202160B (en) | 2003-08-27 |
| NZ517538A (en) | 2003-07-25 |
| IL148166A0 (en) | 2002-09-12 |
| KR20020027562A (en) | 2002-04-13 |
| WO2001013922A1 (en) | 2001-03-01 |
| BR0013416A (en) | 2002-04-30 |
| HUP0202396A2 (en) | 2002-11-28 |
| CA2381302A1 (en) | 2001-03-01 |
| EP1214079A1 (en) | 2002-06-19 |
| CN1370071A (en) | 2002-09-18 |
| HUP0202396A3 (en) | 2005-02-28 |
| SK2382002A3 (en) | 2002-09-10 |
| Publication | Publication Date | Title |
|---|---|---|
| AU7842500A (en) | System for orthopedic treatment | |
| AU6777300A (en) | Treatment apparatus for wounds | |
| AU5602500A (en) | System for orthopedic treatment protocol | |
| HUP0200556A3 (en) | Medicament for treating diabetes | |
| AU1050401A (en) | Device for cardiac therapy | |
| AU5259100A (en) | Medicament | |
| AU7085900A (en) | Airway treatment apparatus | |
| AU6908500A (en) | Treatment for narcolepsy | |
| IL138784A0 (en) | Treatment for diabetes | |
| AU5089400A (en) | Arthritis treatment | |
| AU5547000A (en) | Novel treatment | |
| AU2002210462A1 (en) | Transdermal therapeutic system for treating restless-legs-syndrome | |
| AU773240C (en) | Medicament for treating hypertension | |
| AU3988099A (en) | Combination therapy for treating hypercholesterolemia | |
| AUPQ232599A0 (en) | Drug for treating fractures | |
| AU4770800A (en) | Body treatment product | |
| AU2266801A (en) | Combination therapy for treating neurodegenerative disease | |
| AU2002349268A1 (en) | Medicine for preventing and treating bromidrosis | |
| AU4556800A (en) | Novel treatment | |
| AU1972200A (en) | Treatment for fabrics | |
| AUPQ367699A0 (en) | Treatment of cancer | |
| AU5552400A (en) | Treatment of cancer | |
| AU1618901A (en) | Treatment of rosacea | |
| HU9902296D0 (en) | Pharmaceutical composition for treating caltification | |
| AU5847299A (en) | Medical device for treating narrow nostrils |
| Date | Code | Title | Description |
|---|---|---|---|
| NAA1 | Application designating australia and claiming priority from australian document | Ref document number:6548800 Country of ref document:AU |